Detection of Novel BEST1 Variations in Autosomal Recessive Bestrophinopathy Using Third-generation Sequencing

Abstract

Objective

Autosomal recessive bestrophinopathy (ARB), a retinal degenerative disease, is characterized by central visual loss, yellowish multifocal diffuse subretinal deposits, and a dramatic decrease in the light peak on electrooculogram. The potential pathogenic mechanism involves mutations in the BEST1 gene, which encodes Ca²⁺-activated Cl⁻ channels in the retinal pigment epithelium (RPE), resulting in degeneration of RPE and photoreceptor. In this study, the complete clinical characteristics of two Chinese ARB families were summarized.

Methods

Pacific Biosciences (PacBio) single-molecule real-time (SMRT) sequencing was performed on the probands to screen for disease-causing gene mutations, and Sanger sequencing was applied to validate variants in the patients and their family members.

Results

Two novel mutations, c.202T>C (chr11:61722628, p.Y68H) and c.867+97G>A, in the BEST1 gene were identified in the two Chinese ARB families. The novel missense mutation BEST1 c.202T>C (p.Y68H) resulted in the substitution of tyrosine with histidine in the N-terminal region of transmembrane domain 2 of bestrophin-1. Another novel variant, BEST1 c.867+97G>A (chr11:61725867), located in intron 7, might be considered a regulatory variant that changes allele-specific binding affinity based on motifs of important transcriptional regulators.

Conclusion

Our findings represent the first use of third-generation sequencing (TGS) to identify novel BEST1 mutations in patients with ARB, indicating that TGS can be a more accurate and efficient tool for identifying mutations in specific genes. The novel variants identified further broaden the mutation spectrum of BEST1 in the Chinese population.

Keywords

autosomal recessive bestrophinopathy / BEST1 gene / third-generation sequencing / mutation

References

[1] MarquardtA, StöhrH, PassmoreLA, et al.. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best’s disease). Hum Mol Genet, 1998, 7(9): 1517-1525

[2] MarmorsteinAD, MarmorsteinLY, RaybornM, et al.. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci USA, 2000, 97(23): 12758-12763

[3] PetrukhinK, KoistiMJ, BakallB, et al.. Identification of the gene responsible for Best macular dystrophy. Nat Genet, 1998, 19(3): 241-247

[4] BurgessR, MillarID, LeroyBP, et al.. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet, 2008, 82(1): 19-31

[5] AllikmetsR, SeddonJM, BernsteinPS, et al.. Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies. Hum Genet, 1999, 104(6): 449-453

[6] YardleyJ, LeroyBP, Hart-HoldenN, et al.. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci, 2004, 45(10): 3683-3689

[7] DavidsonAE, MillarID, UrquhartJE, et al.. Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. Am J Hum Genet, 2009, 85(5): 581-592

[8] HabibiI, FalfoulY, TodorovaMG, et al.. Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy (ARB). Genes (Basel), 2019, 10(12): 953

[9] PoplinR, ChangPC, AlexanderD, et al.. A universal SNP and small-indel variant caller using deep neural networks. Nat Biotechnol, 2018, 36(10): 983-987

[10] WangK, LiM, HakonarsonH. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res, 2010, 38(16): e164

[11] TianR, YangG, WangJ, et al.. Screening for BEST1 gene mutations in Chinese patients with bestrophinopathy. Mol Vis, 2014, 20: 1594-1604

[12] PetersenBS, FredrichB, HoeppnerMP, et al.. Opportunities and challenges of whole-genome and -exome sequencing. BMC Genet, 2017, 18(1): 14

[13] SalzbergSL, YorkeJA. Beware of mis-assembled genomes. Bioinformatics, 2005, 21(24): 4320-4321

[14] GuanP, SungWK. Structural variation detection using next-generation sequencing data: A comparative technical review. Methods, 2016, 102: 36-49

[15] BayegaA, WangYC, OikonomopoulosS, et al.. Transcript Profiling Using Long-Read Sequencing Technologies. Methods Mol Biol, 2018, 1783: 121-147

[16] SteijgerT, AbrilJF, EngströmPG, et al.. Assessment of transcript reconstruction methods for RNA-seq. Nat Methods, 2013, 10(12): 1177-1184

[17] ConlinLK, Aref-EshghiE, McEldrewDA, et al.. Long-read sequencing for molecular diagnostics in constitutional genetic disorders. Hum Mutat, 2022, 43(11): 1531-1544

[18] MilenkovicVM, RiveraA, HorlingF, et al.. Insertion and topology of normal and mutant bestrophin-1 in the endoplasmic reticulum membrane. J Biol Chem, 2007, 282(2): 1313-1321

[19] MilenkovicA, MilenkovicVM, WetzelCH, et al.. BEST1. Hum Mol Genet, 2018, 27(9): 1630-1641

[20] MarmorsteinAD, KinnickTR, StantonJB, et al.. Bestrophin-1 influences transepithelial electrical properties and Ca²⁺ signaling in human retinal pigment epithelium. Mol Vis, 2015, 21: 347-359

[21] RosenthalR, BakallB, KinnickT, et al.. Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells. FASEB J, 2006, 20(1): 178-180

[22] StraußO, MüllerC, ReichhartN, et al.. The role of bestrophin-1 in intracellular Ca(2+) signaling. Adv Exp Med Biol, 2014, 801: 113-119

[23] GaoFJ, QiYH, HuFY, et al.. Mutation spectrum of the bestrophin-1 gene in a large Chinese cohort with bestrophinopathy. Br J Ophthalmol, 2020, 104(6): 846-851

[24] QuZ, HartzellC. Determinants of anion permeation in the second transmembrane domain of the mouse bestrophin-2 chloride channel. J Gen Physiol, 2004, 124(4): 371-382

[25] UggentiC, BriantK, StreitAK, et al.. Restoration of mutant bestrophin-1 expression, localisation and function in a polarised epithelial cell model. Dis Model Mech, 2016, 9(11): 1317-1328

[26] DavidsonAE, MillarID, Burgess-MullanR, et al.. Functional characterization of bestrophin-1 missense mutations associated with autosomal recessive bestrophinopathy. Invest Ophthalmol Vis Sci, 2011, 52(6): 3730-3736

[27] JohnsonAA, BachmanLA, GillesBJ, et al.. Autosomal Recessive Bestrophinopathy Is Not Associated With the Loss of Bestrophin-1 Anion Channel Function in a Patient With a Novel BEST1 Mutation. Invest Ophthalmol Vis Sci, 2015, 56(8): 4619-4630

[28] JohnsonAA, LeeYS, ChadburnAJ, et al.. Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1. Exp Eye Res, 2014, 121: 74-85

[29] KinnickTR, MullinsRF, DevS, et al.. Autosomal recessive vitelliform macular dystrophy in a large cohort of vitelliform macular dystrophy patients. Retina, 2011, 31(3): 581-595

[30] GerthC, ZawadzkiRJ, WernerJS, et al.. Detailed analysis of retinal function and morphology in a patient with autosomal recessive bestrophinopathy (ARB). Doc Ophthalmol, 2009, 118(3): 239-246

[31] BoonCJ, van den BornLI, VisserL, et al.. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options. Ophthalmology, 2013, 120(4): 809-820

[32] XiaoQ, HartzellHC, YuK. Bestrophins and retinopathies. Pflugers Arch, 2010, 460(2): 559-569